[News Release: FDA Advisory Committe Recommends Approval of Retrovir (AZT) for HIV-Positive Pregnant Wome and Infants]

One of 15 items in the series: AIDS - AZT Treatment available on this site.
Thumbnail image of item number 1 in: '[News Release: FDA Advisory Committe Recommends Approval of Retrovir (AZT) for HIV-Positive Pregnant Wome and Infants]'.
Thumbnail image of item number 2 in: '[News Release: FDA Advisory Committe Recommends Approval of Retrovir (AZT) for HIV-Positive Pregnant Wome and Infants]'.
Thumbnail image of item number 3 in: '[News Release: FDA Advisory Committe Recommends Approval of Retrovir (AZT) for HIV-Positive Pregnant Wome and Infants]'.
Thumbnail image of item number 4 in: '[News Release: FDA Advisory Committe Recommends Approval of Retrovir (AZT) for HIV-Positive Pregnant Wome and Infants]'.

Description

A news release from Burrough Wellcome Co. about their brand of zidovudine (AZT), Retrovir, being approved by the FDA to reduce the risk of HIV transmission from pregnant mothers to their infants.

Physical Description

[2] p. ; 28 cm.

Creation Information

Burroughs Wellcome Co. 1987.

Context

This text is part of the collection entitled: LGBT Collections and was provided by the UNT Libraries Special Collections to the UNT Digital Library, a digital repository hosted by the UNT Libraries. It has been viewed 516 times. More information about this text can be viewed below.

Who

People and organizations associated with either the creation of this text or its content.

Attributed name

Provided By

UNT Libraries Special Collections

The Special Collections Department collects and preserves rare and unique materials including rare books, oral histories, university archives, historical manuscripts, maps, microfilm, photographs, art and artifacts. The department is located in UNT's Willis Library in the fourth floor Reading Room.

About | Browse this Partner

Contact Us

Corrections Questions

What

Descriptive information to help identify this text. Follow the links below to find similar items on the Digital Library.

Titles

  • Main Title: [News Release: FDA Advisory Committe Recommends Approval of Retrovir (AZT) for HIV-Positive Pregnant Wome and Infants]
  • Series Title: AIDS - AZT Treatment

Description

A news release from Burrough Wellcome Co. about their brand of zidovudine (AZT), Retrovir, being approved by the FDA to reduce the risk of HIV transmission from pregnant mothers to their infants.

Physical Description

[2] p. ; 28 cm.

Language

Item Type

Identifier

Unique identifying numbers for this text in the Digital Library or other systems.

Publication Information

  • Preferred Citation: Dennis Vercher Collection (The Dallas Way) (AR0789), University of North Texas Special Collections

Collections

This text is part of the following collections of related materials.

LGBT Collections

Publications pertaining to issues relevant to the LGBT community. The collection includes The Dallas Voice, a weekly newspaper for the gay community in North Texas that has been published since 1984.

About | Browse this Collection

Dennis Vercher Collection (The Dallas Way)

Named for journalist and activist Dennis Vercher. These materials, which include correspondence, newspaper clippings, financial documentation and press releases, relate to LGBT activism, legislation and HIV/AIDS.

About | Browse this Collection

What responsibilities do I have when using this text?

Digital Files

When

Dates and time periods associated with this text.

Creation Date

  • 1987

Covered Time Period

Added to The UNT Digital Library

  • April 29, 2016, 10:06 p.m.

Description Last Updated

  • Nov. 4, 2021, 7:12 p.m.

Usage Statistics

When was this text last used?

Yesterday: 0
Past 30 days: 0
Total Uses: 516
More Statistics

Where

Geographical information about where this text originated or about its content.

Place Name

Map Information

  • map marker Place Name coordinates. (May be approximate.)
  • Repositioning map may be required for optimal printing.

Mapped Locations

Interact With This Text

Here are some suggestions for what to do next.

Start Reading

Thumbnail image of item number 1 in: '[News Release: FDA Advisory Committe Recommends Approval of Retrovir (AZT) for HIV-Positive Pregnant Wome and Infants]'.
Thumbnail image of item number 2 in: '[News Release: FDA Advisory Committe Recommends Approval of Retrovir (AZT) for HIV-Positive Pregnant Wome and Infants]'.
Thumbnail image of item number 3 in: '[News Release: FDA Advisory Committe Recommends Approval of Retrovir (AZT) for HIV-Positive Pregnant Wome and Infants]'.
Thumbnail image of item number 4 in: '[News Release: FDA Advisory Committe Recommends Approval of Retrovir (AZT) for HIV-Positive Pregnant Wome and Infants]'.

Citations, Rights, Re-Use

International Image Interoperability Framework

IIF Logo

We support the IIIF Presentation API

Links for Robots

Helpful links in machine-readable formats.

Archival Resource Key (ARK)

International Image Interoperability Framework (IIIF)

Metadata Formats

Images

URLs

Stats

Burroughs Wellcome Co. [News Release: FDA Advisory Committe Recommends Approval of Retrovir (AZT) for HIV-Positive Pregnant Wome and Infants], text, 1987; (https://digital.library.unt.edu/ark:/67531/metadc824974/: accessed April 24, 2024), University of North Texas Libraries, UNT Digital Library, https://digital.library.unt.edu; crediting UNT Libraries Special Collections.

Back to Top of Screen